Nancy Pelosi just made Tempus AI (TEM) the stock of the moment. The former Speaker of the House quietly purchased 50 call ...
Jennifer Doudna, a director at Tempus AI , Inc. (NASDAQ:TEM), recently sold a portion of her holdings in the company. According to a recent SEC filing, Doudna sold 1,320 shares of Tempus AI's Class A ...
Ryan M. Bartolucci, the Chief Accounting Officer of Tempus AI , Inc. (NASDAQ:TEM), sold 6,059 shares of the company's Class A common stock on February 13, 2025. The timing is notable as TEM shares ...
Personalis shows promise in cancer detection but is years away from profitability. Read why PSNL stock is rated a hold with ...
Tempus AI (TEM) stock surged 13.4% on Thursday, hitting a new 52-week high of $86. The upside came after the health ...
Artera and Tempus are collaborating to expand access to Artera’s AI-based prostate cancer test. Currently connected to more ...
Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, and Tempus, ...
Regarding the transaction, the lawmaker disclosed on January 14 the accumulation of 50 call options in Tempus AI with a ...
Tempus AI, Inc. , a leader in artificial intelligence and precision medicine, today announced they will report financial results for the fourth quarter and full year 2024 on Monday, February 24, 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results